A detailed history of Bank Of Montreal transactions in Neogenomics Inc stock. As of the latest transaction made, Bank Of Montreal holds 94,591 shares of NEO stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,591
Previous 98,741 4.2%
Holding current value
$1.32 Million
Previous $1.55 Million 15.53%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$13.01 - $15.77 $53,991 - $65,445
-4,150 Reduced 4.2%
94,591 $1.31 Million
Q1 2024

May 13, 2024

SELL
$14.06 - $16.79 $156,389 - $186,755
-11,123 Reduced 10.12%
98,741 $1.55 Million
Q4 2023

Feb 08, 2024

BUY
$11.67 - $20.73 $33,562 - $59,619
2,876 Added 2.69%
109,864 $1.78 Million
Q3 2023

Nov 01, 2023

BUY
$12.15 - $17.85 $885,965 - $1.3 Million
72,919 Added 214.03%
106,988 $1.32 Million
Q2 2023

Aug 02, 2023

BUY
$14.1 - $19.83 $108,978 - $153,266
7,729 Added 29.34%
34,069 $547,000
Q1 2023

Jun 13, 2024

SELL
$9.09 - $19.45 $607,357 - $1.3 Million
-66,816 Reduced 67.67%
31,925 $555,000
Q4 2022

Feb 01, 2023

SELL
$6.45 - $12.07 $20,885 - $39,082
-3,238 Reduced 10.95%
26,340 $243,000
Q3 2022

Nov 10, 2022

BUY
$7.86 - $12.91 $103,021 - $169,211
13,107 Added 79.58%
29,578 $289,000
Q2 2022

Aug 11, 2022

SELL
$7.06 - $13.97 $174,614 - $345,520
-24,733 Reduced 60.03%
16,471 $152,000
Q1 2022

May 12, 2022

BUY
$12.15 - $35.28 $29,123 - $84,566
2,397 Added 6.18%
41,204 $535,000
Q4 2021

Feb 11, 2022

SELL
$30.49 - $48.49 $586,566 - $932,850
-19,238 Reduced 33.14%
38,807 $1.33 Million
Q3 2021

Nov 12, 2021

BUY
$41.66 - $52.52 $6,790 - $8,560
163 Added 0.28%
58,045 $2.83 Million
Q2 2021

Aug 12, 2021

BUY
$36.62 - $51.69 $2.12 Million - $2.99 Million
57,882 New
57,882 $2.71 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.75B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.